Clinical Trials Browser

Phase 2 × Central Nervous System Neoplasms × rubitecan × Clear all

NCT00005826 2012-09-24

Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme

Phase 2 Completed

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma